Asthma Drug May Prevent Migraines

Asthma Drug May Prevent Migraines

Asthma Drug May Prevent Migraines

Singulaire (montelukast sodium), a commonly used asthma medicine approved to treat children over 2 years of age, is reported to prevent headaches in adults.

At the 2001 annual Congress of the International Headache Society, researchers presented a study using Singulaire to prevent headaches in children and adolescents. Everyone in the study had a greater than 50% reduction in their number of headaches while taking the medicine. Overall, the group went from an average of 15.8 headaches per month down to 3.5 monthly headaches! No side effects were reported.

Further research is needed, but these initial results are promising. Children’s migraines are often under-diagnosed and under treated. Preventing, on average, 12 significant headaches a month must have felt wonderful to these children.

Dr. Alan Greene

Article written by

Dr. Greene is the founder of DrGreene.com (cited by the AMA as “the pioneer physician Web site”), a practicing pediatrician, father of four, & author of Raising Baby Green & Feeding Baby Green. He appears frequently in the media including such venues as the The New York Times, the TODAY Show, Good Morning America, & the Dr. Oz Show.

 

Comments